Literature DB >> 23259403

Reconstruction of an in vitro niche for the transition from intervertebral disc development to nucleus pulposus regeneration.

Mark Shoukry1, Jingting Li, Ming Pei.   

Abstract

The nucleus pulposus (NP) plays a prominent role in both the onset and progression of intervertebral disc degeneration. While autologous repair strategies have demonstrated some success, their in vitro culture system is outdated and insufficient for maintaining optimally functioning cells through the required extensive passaging. Consequently, the final population of cells may be unsuitable for the overwhelming task of repairing tissue in vivo and could result in subpar clinical outcomes. Recent work has identified synovium-derived stem cells (SDSCs) as a potentially important new candidate. This population of precursors can promote matrix regeneration and additionally restore the balance of catabolic and anabolic metabolism of surrounding cells. Another promising application is their ability to produce an extracellular matrix in vitro that can be modified via decellularization to produce a tissue-specific substrate for efficient cell expansion, while retaining chondrogenic potential. When combined with hypoxia, soluble factors, and other environmental regulators, the resultant complex microenvironment will more closely resemble the in vivo niche, which further improves the cell capacity, even after extensive passaging. In this review, the adaptive mechanisms NP cells utilize in vivo are considered for insight into what factors are important for constructing a tissue-specific in vitro niche. Evidence for the use of SDSCs for NP regeneration is also discussed. Many aspects of NP behavior are still unknown, which could lead to future work yielding key information on producing sufficient numbers of a high-quality NP-specific population that is able to regenerate deteriorated NP in vivo.

Entities:  

Mesh:

Year:  2013        PMID: 23259403      PMCID: PMC3613965          DOI: 10.1089/scd.2012.0597

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  173 in total

1.  Optimization of an in vitro three-dimensional microenvironment to reprogram synovium-derived stem cells for cartilage tissue engineering.

Authors:  Jingting Li; Ming Pei
Journal:  Tissue Eng Part A       Date:  2010-12-18       Impact factor: 3.845

Review 2.  The role of the physicochemical environment in determining disc cell behaviour.

Authors:  J P G Urban
Journal:  Biochem Soc Trans       Date:  2002-11       Impact factor: 5.407

Review 3.  Nutrition of the intervertebral disc.

Authors:  Jill P G Urban; Stanton Smith; Jeremy C T Fairbank
Journal:  Spine (Phila Pa 1976)       Date:  2004-12-01       Impact factor: 3.468

Review 4.  A review of decellularized stem cell matrix: a novel cell expansion system for cartilage tissue engineering.

Authors:  M Pei; J T Li; M Shoukry; Y Zhang
Journal:  Eur Cell Mater       Date:  2011-11-24       Impact factor: 3.942

5.  Hypoxia activates MAPK activity in rat nucleus pulposus cells: regulation of integrin expression and cell survival.

Authors:  Makarand V Risbud; Asha Guttapalli; Todd J Albert; Irving M Shapiro
Journal:  Spine (Phila Pa 1976)       Date:  2005-11-15       Impact factor: 3.468

6.  Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source.

Authors:  Yusuke Sakaguchi; Ichiro Sekiya; Kazuyoshi Yagishita; Takeshi Muneta
Journal:  Arthritis Rheum       Date:  2005-08

7.  Comparative expression of matrix-associated genes and inflammatory cytokines-associated genes according to disc degeneration: analysis of living human nucleus pulposus.

Authors:  Jeong Yoon Park; Sung Uk Kuh; Hyo Suk Park; Keun Su Kim
Journal:  J Spinal Disord Tech       Date:  2011-08

8.  Distinction between the extracellular matrix of the nucleus pulposus and hyaline cartilage: a requisite for tissue engineering of intervertebral disc.

Authors:  F Mwale; P Roughley; J Antoniou
Journal:  Eur Cell Mater       Date:  2004-12-15       Impact factor: 3.942

9.  Uridine diphosphoglucose dehydrogenase activity in normal and rheumatoid synovium: the description of a specialized synovial lining cell.

Authors:  A A Pitsillides; L S Wilkinson; S Mehdizadeh; M T Bayliss; J C Edwards
Journal:  Int J Exp Pathol       Date:  1993-02       Impact factor: 1.925

10.  Reconstruction of an in vitro tissue-specific microenvironment to rejuvenate synovium-derived stem cells for cartilage tissue engineering.

Authors:  Fan He; Xiaodong Chen; Ming Pei
Journal:  Tissue Eng Part A       Date:  2009-12       Impact factor: 3.845

View more
  5 in total

1.  Activation of autophagy via Ca(2+)-dependent AMPK/mTOR pathway in rat notochordal cells is a cellular adaptation under hyperosmotic stress.

Authors:  Li-Bo Jiang; Lu Cao; Xiao-Fan Yin; Miersalijiang Yasen; Mumingjiang Yishake; Jian Dong; Xi-Lei Li
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 2.  The Challenge in Using Mesenchymal Stromal Cells for Recellularization of Decellularized Cartilage.

Authors:  Zhao Huang; Owen Godkin; Gundula Schulze-Tanzil
Journal:  Stem Cell Rev Rep       Date:  2017-02       Impact factor: 5.739

Review 3.  Meniscus, articular cartilage and nucleus pulposus: a comparative review of cartilage-like tissues in anatomy, development and function.

Authors:  Song Chen; Peiliang Fu; Haishan Wu; Ming Pei
Journal:  Cell Tissue Res       Date:  2017-04-17       Impact factor: 5.249

4.  Impact of Wnt signals on human intervertebral disc cell regeneration.

Authors:  Tyler Pizzute; Fan He; Xiao-Bing Zhang; Ming Pei
Journal:  J Orthop Res       Date:  2018-08-06       Impact factor: 3.494

5.  The effects of human Wharton's jelly cell transplantation on the intervertebral disc in a canine disc degeneration model.

Authors:  Yan Zhang; Hui Tao; Tao Gu; Mingyue Zhou; Zhiwei Jia; Gangqiang Jiang; Chun Chen; Zhihua Han; Cheng Xu; Deli Wang; Qing He; Dike Ruan
Journal:  Stem Cell Res Ther       Date:  2015-08-27       Impact factor: 6.832

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.